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Complicated epilepsyAbstract Epilepsy is a common chronic neurological disorder in pediatric age characterized by
recurrent, unprovoked seizures; these seizures are transient signs of abnormal excessive or hyper
synchronous neuronal activity in the brain. Complicated epilepsy is associated with high seizure fre-
quency, prolonged seizures and may lead to some sort of cardiac ischemia, myocardial injury and
elevated serum CTnI.
Aim: A possible importance of Cardiac troponin I (CTnI) level in epileptic children.
Patients and methods: The study was carried out upon 90 children, classiﬁed into three groups:
Group I: 30 with uncomplicated epilepsy. Group II: 30 with complicated epilepsy. Group III (con-
trol): 30 apparently clinically healthy children with similar age and sex. All groups were subjected to
the following: full history taking – thorough clinical examination – EEG – assessment of serum car-
diac troponin I- and CT only for groups I and II.
Results: Our research revealed a signiﬁcant statistical increase in the cardiac troponin level (CTnI)
maximum in group II followed by group I then lastly group III and revealed a direct correlation
between cardiac troponin I and presence of prenatal problem, mental retardation, EEG abnormal-
ity and abnormal C T or MRI. There was an indirect correlation between cardiac troponin I and
age of seizure onset. Also there was one between cardiac troponin I and etiology of epilepsy.
Conclusion: Cardiac troponin I is a perfect tool for early detection of cases with myocardial dys-
function in epileptic patients – cardiac troponin I is signiﬁcantly increased in children with epilepsy
especially the complicated epilepsy. Cardiac injury in epileptic children is more common in patients
with early onset epilepsy, positive prenatal problem, idiopathic epilepsy, abnormal imaging and
EEG – elevated TnI levels may be of value in assessing the severity and eventual outcome and mor-
tality risk of the disease in children with epilepsy.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.
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Epilepsy is one of the most common and challenging neuro-
logical disorders affecting children. The cumulative life time
incidence of epilepsy is now considered to be 3% where
more than half of the cases begin in childhood.1 Epilepsy
has been deﬁned as recurrent convulsive and non convulsive
seizures caused by partial or generalized epileptogenic dis-
charge in the cerebrum.2 An epileptic seizure is the result
of temporary physiologic dysfunction of the brain caused
by a self-limited abnormal, hypersynchronous electrical dis-
charge from cortical neurons.3 Epilepsy has been proved
to cause neurodegeneration and progressive brain damage,
neuroprotection seems to play a crucial role in the manage-
ment of the disease.4 Cardiac troponin I (CTnI) is a myo-
ﬁbrillar protein regulating the interaction of actin and
myosin. It is 100% tissue speciﬁc for the heart and is an
excellent serum marker for detecting myocardial injury. Car-
diac troponin I (CTnI) is released into the circulation in re-
sponse to ischemic and non-ischemic cardiac injury.
Concentrations of both troponin begin to rise in the 4–8 h fol-
lowing injury and peak at 12–24 h. Cardiac troponin T may
remain raised for more than two weeks and CTnI for more
than 5–7 days.5 Based on previous studies, contradictory re-
sults have been reported about elevation of serum levels of
CTnI in patients presenting with sub-acute or acute neuro-
logical disorders with or without seizures.6
2. Aim of the work
Study of serum Cardiac troponin I (CTnI) level as a biomarker
for cardiac injury in epileptic children.
3. Patients and methods
The present study was conducted on 90 children (60 epilep-
tic patients, 30 apparently healthy children as control) di-
vided into 46 boys and 44 girls aged from 4 month toTable 1 Electroencephalogram ﬁndings among all studied groups.
EEG Group
Group I Group II
No. % No.
EEG
Normal 18 60 9
Abnormal 12 40 21
EEG abnormality
Focal 3 10 9
Generalized 8 26.6 9
Focal with 2ry Generalization 1 3.3 3
Site of focal activity
Frontal 2 6.6 9
Temporal 1 3.3 0
Occipital 0 .0 0
Central 0 .0 0
There was a statistically signiﬁcant difference between the studied group
difference between the studied groups regarding the types of EEG abnor
*Signiﬁcant.
** Highly signiﬁcant.17 years attending the pediatric outpatient neurology clinic,
Menoﬁya University, during the period from January to
June 2012. The diagnosis of epilepsy was based on history,
clinical examination, and Electroencephalogram. The study
compromised 60 epileptic patients with the following inclu-
sion criteria: both sexes are included – known patients of
epilepsy – patients with history of an attack of seizure dur-
ing last week.
The exclusion criteria for the study: patients with single
unprovoked seizure – cardiac patients – patients with other
diseases or illnesses that might affect CVS (cardio vascular sys-
tem) & ANS (autonomic nervous system), e.g. SLE, endocrinal
and metabolic disorders – patients on any regular medication,
other than the antiepileptic drugs, that might affect CVS and
ANS – patients with acute illness till cured.
All children in the study were further classiﬁed to three
groups:
Group I: Included 30 children diagnosed with uncompli-
cated epilepsy, (epilepsy with no neurological abnormality
except seizures) they were randomly selected, their age ran-
ged from 4 months to 17 years (with mean age
6 ± 3.41 years), 12 males and 18 females. (The selected
patients were initially assessed.)
Group II: Included 30 children diagnosed with complicated
epilepsy, (epilepsy associated with abnormal neurological
examination) they were randomly selected, their age ranged
from 4 month to 17 years (with mean age 4.63 ± 4.32 years),
16 males and 14 females. (The selected patients were initially
assessed.)
Group III (control group): 30 apparently clinically healthy
children, they were randomly selected, their age ranged
from 4 month to 17 years (with mean age 6.32 ± 4.11 years),
15 males and 15 females, matching the patients in their age,
sex. They were selected from the same population and age
groups to which the patient belonged with no history suggest-
ing epilepsy or other medical, metabolic, neurological or psy-
chiatric disorders.X2 p. Value
Group III Total
% No. % No. %
30.0 30 100 57 63.3 31.88 p< 0.01**
70.0 0 .0 33 36.7
30 0 .0 12 13.3 0.6 p> 0.05
30 0 .0 17 18.9
10 0 .0 4 4.4
30 0 .0 11 12.2 3.2 p> 0.05
.0 0 .0 1 1.1
.0 0 .0 0 .0
.0 0 .0 0 .0
s regarding the EEG ﬁndings – there was no statistically signiﬁcant
mality, site of focal activity.
Table 2 Cardiac troponin I level among all studied groups.
Cardiac troponin I level Group X2 p. Value
Group I Group II Group III Total
No. % No. % No. % No. %
CTn I level Normal 21 70.0 5 16.7 26 86.7 52 57.8 32.9 p< 0.01**
Abnormal al 9 30.0 25 83.3 4 13.3 38 42.2
There was a statistically signiﬁcant difference between the studied groups regarding the cardiac troponin level (CTnI) among all studied groups.
*Signiﬁcant.
** Highly signiﬁcant.
Table 3 Cardiac troponin I level in relation to the onset of seizures among all studied groups.
Group I Group II Total X2 p. Value
No. % No. % No. %
Age at onset Neonatal CTnI level Normal 0 .0 1 11.1 1 11.1 – –
Abnormal 0 .0 8 88.9 8 88.9
Infant CTnI level Normal 7 58.3 2 13.3 9 33.3 6.1 p< 0.05*
Abnormal 5 41.7 13 86.7 18 66.7
Childhood CTnI level Normal 14 77.8 2 33.3 16 66.7 4 p< 0.05*
Abnormal 4 22.2 4 66.7 8 33.3
There was a statistically signiﬁcant difference between the studied groups regarding the cardiac troponin level (CTnI) in relation to the onset of
seizures.
* Signiﬁcant.
** Highly signiﬁcant.
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Group X2 p. Value
Group I Group II Group III Total
No. % No. % No. % No. %
Prenatal Problem No CTnI level Normal 18 66.7 1 7.7 26 86.7 45 64.3 24.7 p< 0.01**
Abnormal 9 33.3 12 92.3 4 13.3 25 35.7
Yes CTnI level Normal 3 100.0 4 23.5 0 .0 7 35.0 6.5 p< 0.05*
Abnormal 0 .0 13 76.5 0 .0 13 65.0
There was a statistically signiﬁcant difference between the studied groups regarding the cardiac troponin level(CTnI) in relation to the prenatal
problem.
* Signiﬁcant.
** Highly signiﬁcant.
Table 5 Cardiac troponin I level in relation to etiology of seizures among all studied groups.
Group Group Total X2 p. Value
No. % No. % No. %
Etiology Idiopathic CTnI level Normal 18 66.7 1 10.0 19 51.4 9.4 p< 0.01**
Abnormal 9 33.3 9 90.0 18 48.6
Secondary CTnI level Normal 3 100.0 4 20.0 7 30.4 7.9 p< 0.01**
Abnormal 0 .0 16 80.0 16 69.6
There was a statistically signiﬁcant difference between the studied groups regarding the cardiac troponin level(CTnI) in relation to etiology.
*Signiﬁcant.
** Highly signiﬁcant.
Table 6 Cardiac troponin I level in relation to neuro imaging among all studied groups.
Groups X2 p. Value
Group I Uncomplicated
epilepsy (N = 30)
Group II Complicated
epilepsy (N = 30)
Total
(N= 60)
No. % No. % No. %
CT. Or MRI Normal CTnI level Normal 21 77.8 1 .0 48 53.3 17.7 p< 0.01**
Abnormal 6 22.2 4 100 14 15.6
Abnormal CTnI level Normal 0 .0 4 20 4 4.4 0.4 p> 0.05
Abnormal 3 100.0 21 80 24 26.6
There was a statistically signiﬁcant difference between the studied groups regarding the cardiac troponin level (CTnI) in relation to normal
neuro imaging. There was no statistically signiﬁcant difference between the studied groups regarding the cardiac troponin level (CTnI) in
relation to abnormal neuroimaging.
*Signiﬁcant.
** Highly signiﬁcant.
Table 7 Cardiac troponin I level in relation to EEG among all studied groups.
Group X2 p Value
Group I Group II Group III Total
No. % No. % No. % No. %
EEG Normal CTnI level Normal 13 77.8 3 33.3 26 86.7 42 46.7 10.7 p< 0.01**
Abnormal 5 22.2 6 66.7 4 13.3 15 16.6
Abnormal CTnI level Normal 8 58.3 2 9.5 0 .0 10 11.1 9.2 p< 0.01**
Abnormal 4 41.7 19 90.5 0 .0 23 25.6
There was a statistically signiﬁcant difference between the studied groups regarding the cardiac troponin level (CTnI) in relation to EEG.
*Signiﬁcant.
** Highly signiﬁcant.
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After approval of the ethics committee, informed consents
were obtained from the parents of the selected children and
from adolescent patients.
All the selected patients were subjected to the following:
(A) Full history taking: Careful medical history taking as
name, age, sex, and the neurological history obtainedwith
focus on the convulsion (time of appearance, course, fre-
quency, severity of seizures, anddurationof disease), fam-
ily history of epilepsy, dose and duration of the drug,
frequency of intake and control on medication.
(B) Thorough clinical examination:
1. General, respiratory, cardiac and abdominal examinations.
2. Local examinationwith special emphasis on full neurological
examination. With stress on mental status, cranial nerves
affection, muscle tone, muscle power and reﬂexes.
3. Electroencephalogram (inter-ictal). (using Ebneuro-Galilio-
Sirius serial no. o1139) Conventional interictal awake or
sleep EEG was done for each patient using digital EEG.
4. Computerized tomography or magnetic resonance imaging of
thebrain.Computerized tomographyof thebrain (usingPicker
PQ CT model no. 171930, serial no. 4586) for groups I and II.
5. Measurement of serum cardiac troponin (CTnI): by Accu-
Bind Troponin-I (CTnI) Micro plate ELISA. Product
Code: 3825-300. The value that is considered normal for
TCn1: usually it is 0, but up to 0.1 can be normal because
of some technique noise.5. Results
Results are shown in Tables 1–7 and Figs. 1–3.
6. Discussion
Electroencephalogram (EEG) plays a central role in the diag-
nosis and management of patients with seizure disorders, be-
cause it is a convenient and relatively inexpensive way to
demonstrate the physiological manifestations of abnormal cor-
tical excitability that underlie epilepsy. Normal EEG does not
exclude epilepsy as around 10% of patients with epilepsy never
show epileptiform discharge. Because epilepsy is an intermit-
tent and unpredictable disorder, most EEGs in patients with
seizures are obtained between rather than during attacks. Pa-
tients who are taking an anticonvulsant and who are scheduled
for a routine EEG should not decrease or discontinue the med-
ication before the study.7
In the study there was a signiﬁcant difference regarding
the EEG abnormalities. About 60% of patients in group I
(uncomplicated epilepsy) and 30% in group II (complicated
epilepsy) had normal EEG. Similar results were obtained by
Andrade et al.8 who show that normal EEG does not ex-
clude the diagnosis of epilepsy because interictal recording
is normal in approximately 40% of patients. Abnormal EEG
had been detected in 70% of patients in group II (complicated
epilepsy) and 40.0% in group I (uncomplicated epilepsy). EEG
Figure 1 Cardiac troponin I level in relation to the onset of
seizures among epileptic groups.
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Figure 3 Cardiac troponin I level in relation to abnormal EEG
among all studied groups.
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Group I Uncomplicated
epilepsy
(N = 30)
Group II Complicated 
epilepsy 
(N = 30)
Group III
Control
(N = 30)
77.80%
33.30%
86.70%
22.20%
66.70%
13.30%
Normal
Abnormal
N
or
m
al
 C
Tn
I l
ev
el
Figure 2 Cardiac troponin I level in relation to normal EEG
among all studied groups.
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group II (complicated epilepsy) and 16.6% in group I (uncom-
plicated epilepsy) These agrees with ﬁnding by Andrade et al.8
who stated that most of the patients with symptomatic epilepsy
had abnormal EEG.
Cardiac troponin I was elevated in about 30% of patients in
group I (uncomplicated epilepsy), while in group II (compli-
cated epilepsy) 83.3% had elevated cardiac troponin I ‘‘CTnI’’.
Similar results were obtained by Colugnati et al.13 In contrast
to current results, Hajsadeghi et al.9 had shown that the serum
troponin level was not higher than the normal range in both
groups of patients though it was signiﬁcantly higher in the
group of patients with complicated seizures when comparedto the uncomplicated group. Del Rey et al.10 had attributed
higher troponin I levels in complicated patients to the negligi-
ble injury of cardiac tissue during seizure.
In the present study there was a signiﬁcant difference
regarding the level of cardiac troponin I ‘‘CTnI’’ in relation
to the age of onset of seizures (p< 0.05), where eight out of
nine patients (88.9%) in group II (complicated epilepsy) with
onset of seizures at neonatal period had abnormal cardiac tro-
ponin I ‘‘CTnI’’ level. While thirteen patients out of ﬁfteen pa-
tients (86.7%) in group II (complicated epilepsy) with onset of
seizures during infancy had abnormal cardiac troponin I
‘‘CTnI’’ level. At the childhood period, four out of six patients
(66.7%) in group II (complicated epilepsy) had abnormal car-
diac troponin I ‘‘CTnI’’ level.
In concordance to current results Hajsadeghi et al.9 stated
that a considerable increase in CTnI indicates seriously af-
fected myocardium in hypoxic newborn and that re-oxygena-
tion with 100% oxygen offered no biochemical beneﬁt over
ambient air.
Within the present study, there was a signiﬁcant relation of
cardiac troponin I ‘‘CTnI’’ level and prenatal problem
(p< 0.01, 0.05). Within group II (complicated epilepsy), there
was a signiﬁcant correlation within the seventeen patients with
prenatal problems where thirteen out of seventeen patients
(76.5%) had positive abnormal cardiac troponin I ‘‘CTnI’’ le-
vel. The same results were obtained by a study done by Cha-
iworapongsa et al.11, who found that troponin I was
marginally elevated in their cases who were neonates of pre-
eclamptic mothers and they attributed this to a mild degree
of myocardial injury allowing them to survive.
In neonates, cardiac troponins T (cTnT) and I (CTnI)
have been shown to identify myocardial injury in asphyxia
Moller et al.12. In the current study there was a signiﬁcant
correlation between the level of cardiac troponin I and etiol-
ogy of epilepsy (p< 0.01). In the group with idiopathic epi-
lepsy nine patients out of ten (90%) and sixteen patients out
of 20 (80%) in the group with secondary epilepsy in group
282 A.A.A. Khattab et al.II (complicated epilepsy) had abnormal cardiac troponin I
‘‘CTnI’’ level.
Patients with abnormal neurological examination usually
experience more severe and frequent epileptic ﬁts which are
usually resistant and intractable to treatment which may ex-
pose these patients to some sort of cardiac ischemia, and so
it is thought that the more severe and frequent the attacks,
the more will be the risk of cardiac ischemia, so we recommend
regular follow up with cardiac troponin I for early detection of
cardiac ischemia especially in patients with severe neurological
deﬁcits.
Within the study groups, there was a statistically signiﬁcant
difference between the cardiac troponin level (CTnI) in rela-
tion to neuro imaging (p< 0.01, 0.05). In addition there was
a statistically signiﬁcant difference between the studied groups
regarding the cardiac troponin level (CTnI) in relation to EEG
(p< 0.01).7. Conclusion
 Cardiac troponin I is a perfect tool for early detection of
cases with myocardial dysfunction in epileptic patients.
 Cardiac troponin I is signiﬁcantly increased in children with
epilepsy especially the complicated epilepsy.
 Cardiac injury in epileptic children is more common in
patients with early onset epilepsy, in patients with positive
prenatal problem, idiopathic epilepsy and mentally retarded
who have abnormal imaging and EEG.
 Elevated TnI levels may be of value in assessing the severity,
eventual outcome and mortality risk of the disease in chil-
dren with epilepsy.
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